Medication info
Atacan Tablets 8 mg (Candesartan Cilexetil)

Atacan Tablets 8 mg (Candesartan Cilexetil)

Prescription medicationTabletOral
Ingredient · strength
Candesartan Cilexetil›8mg / 1 tablet
Manufacturer / importer
Yuhan Corporation
Appearance
Bright pink, biconvex, round tablet
Packaging
30 tablets/bottle, 100 tablets/bottle
Approval status
Active

MFDS item code 199800725 · Approved 1998.07.01 · Insurance code 642100960

Summary

Main use
Treatment of essential hypertension and heart failure with reduced left ventricular systolic function
Who takes it
Adults · Children
Adult dose
Take this medicine at the same time each day, regardless of meals. 1. Essential hypertension 1) Adults: The recommended initial and maintenance dose is 8 ∼ 16 mg of candesartan cilexetil orally once daily. If blood pressure is not adequately controlled after 4 weeks of treatment with 16 mg once daily, the dose may be increased to a maximum of 32 mg once daily. If blood pressure is still not controlled at this dose, other treatments should be considered. The maximum effect is achieved within 4 weeks of starting treatment. 2) Elderly patients: No adjustment of the initial dose is necessary. 3) Patients with intravascular volume depletion: In patients at high risk of hypotension, such as those with volume depletion, administer an initial dose of 4 mg with careful monitoring. 4) Patients with renal impairment: The initial dose for patients with renal impairment, including those undergoing hemodialysis, is 4 mg; adjust the dose according to the patient's response. Experience with use in patients with severe or end-stage renal impairment (creatinine clearance < 15 mL/min) is limited. 5) Patients with hepatic impairment: The initial dose for patients with mild to moderate hepatic impairment is 2 mg once daily; adjust the dose according to the patient's response. There is no experience with use in patients with severe hepatic impairment. 2. Heart failure 1) Adults: The recommended initial dose is 4 mg once daily. The dose may be doubled at intervals of at least 2 weeks, up to a maximum of 32 mg once daily, taking the patient's tolerability into account. 2) Elderly patients, patients with intravascular volume depletion, patients with renal impairment, and patients with mild ∼ moderate hepatic impairment: No adjustment of the initial dose is necessary.
Child dose
1. Essential hypertension 6) Children: Safety and efficacy have not been established in adolescents and children 18 years of age or younger. 2. Heart failure 3) Children: Safety and efficacy have not been established in adolescents and children 18 years of age or younger.

Ingredients

Manufacturer
Yuhan Corporation

Efficacy & effects

Treatment of essential hypertension and heart failure with reduced left ventricular systolic function

  • Essential hypertension
  • heart failure
  • impaired left ventricular systolic function
  • reduced left ventricular ejection fraction
View approved original text

This medication is primarily used to control blood pressure in patients with essential hypertension. Additionally, it is effective in patients with heart failure and impaired left ventricular systolic function, particularly those categorized as NYHA class II to IV with a left ventricular ejection fraction of 40% or less. This medication is beneficial for patients who require additional therapy to ACE inhibitors or who have poor tolerance to ACE inhibitors. It contributes to improving heart function and alleviating symptoms in these patients. Therefore, this drug is used for treating hypertension and heart failure related to left ventricular dysfunction.

How to take

Adult dose

Take this medicine at the same time each day, regardless of meals. 1. Essential hypertension 1) Adults: The recommended initial and maintenance dose is 8 ∼ 16 mg of candesartan cilexetil orally once daily. If blood pressure is not adequately controlled after 4 weeks of treatment with 16 mg once daily, the dose may be increased to a maximum of 32 mg once daily. If blood pressure is still not controlled at this dose, other treatments should be considered. The maximum effect is achieved within 4 weeks of starting treatment. 2) Elderly patients: No adjustment of the initial dose is necessary. 3) Patients with intravascular volume depletion: In patients at high risk of hypotension, such as those with volume depletion, administer an initial dose of 4 mg with careful monitoring. 4) Patients with renal impairment: The initial dose for patients with renal impairment, including those undergoing hemodialysis, is 4 mg; adjust the dose according to the patient's response. Experience with use in patients with severe or end-stage renal impairment (creatinine clearance < 15 mL/min) is limited. 5) Patients with hepatic impairment: The initial dose for patients with mild to moderate hepatic impairment is 2 mg once daily; adjust the dose according to the patient's response. There is no experience with use in patients with severe hepatic impairment. 2. Heart failure 1) Adults: The recommended initial dose is 4 mg once daily. The dose may be doubled at intervals of at least 2 weeks, up to a maximum of 32 mg once daily, taking the patient's tolerability into account. 2) Elderly patients, patients with intravascular volume depletion, patients with renal impairment, and patients with mild ∼ moderate hepatic impairment: No adjustment of the initial dose is necessary.

Child dose

1. Essential hypertension 6) Children: Safety and efficacy have not been established in adolescents and children 18 years of age or younger. 2. Heart failure 3) Children: Safety and efficacy have not been established in adolescents and children 18 years of age or younger.

Precautions

This medication can cause serious harm to the fetus if taken during pregnancy, particularly in the second and third trimesters, and should be discontinued immediately upon confirmation of pregnancy. Do not take this drug if you are allergic to it or any of its components, are pregnant or nursing, have severe liver impairment, or have hereditary angioedema. Elderly patients, those with hyperkalemia, liver impairment, cardiovascular disease, or kidney impairment should exercise caution while using this drug, and dosage adjustments or regular monitoring may be necessary based on their condition. While taking this medication, side effects such as dizziness, back pain, respiratory infections may occur, and heart failure patients may experience hypotension, hyperkalemia, and kidney function impairment, necessitating frequent blood tests to monitor their condition. Severe side effects may include blood disorders, liver dysfunction, myalgia, vascular edema, and acute renal failure, so immediate consultation with healthcare professionals is necessary if any abnormal symptoms occur. This medication may enhance the effects when used with other antihypertensives, and there is an increased risk of hyperkalemia when taken with certain diuretics or potassium supplements, thus caution is advised. Use during pregnancy is risky for the fetus, and it is advisable to avoid use while breastfeeding. Safety in adolescents and children under 18 years of age has not been established, so it is preferable not to use this medication in this age group. Elderly patients should be cautious due to the risk of excessive blood pressure lowering causing stroke and other complications. In cases of overdose, symptoms such as hypotension, dizziness, and tachycardia may occur; appropriate treatment should be administered at a hospital if necessary. Keep this medication out of reach of children, and avoid transferring it to other containers.

Side effects

  • Dizziness
  • back pain
  • respiratory infection
  • asthenia
  • fever
  • paresthesia
  • dyspepsia
  • gastroenteritis
  • tachycardia
  • palpitations
Show 68 more
  • increased creatine kinase
  • hyperglycemia
  • hypertriglyceridemia
  • hyperuricemia
  • myalgia
  • epistaxis
  • anxiety
  • depression
  • somnolence
  • dyspnea
  • rash
  • increased sweating
  • hematuria
  • hypotension
  • hyperkalemia
  • kidney function impairment
  • increased creatinine
  • increased urea
  • fatigue
  • peripheral edema
  • chest pain
  • headache
  • bronchitis
  • cough
  • sinusitis
  • nausea
  • abdominal pain
  • diarrhea
  • vomiting
  • arthralgia
  • proteinuria
  • leukopenia
  • neutropenia
  • agranulocytosis
  • hyponatremia
  • hypoglycemia
  • intestinal vascular edema
  • increased liver enzyme levels
  • hepatitis
  • elevated AST
  • elevated ALT
  • elevated γ-GTP
  • jaundice
  • urticaria
  • pruritus
  • angioedema
  • rhabdomyolysis
  • arthralgia
  • acute renal failure
  • interstitial pneumonia
  • shock
  • syncope
  • loss of consciousness
  • paralysis
  • hypertonia
  • syncope
  • facial flushing
  • weight gain
  • facial edema
  • thirst
  • sleep disorders
  • decreased libido
  • memory impairment
  • decreased appetite
  • increased appetite
  • tinnitus
  • dysgeusia
  • erectile dysfunction

Not everyone experiences these, and they can vary from person to person.

Storage

Store this medication in a tightly closed container to protect it from air or moisture. It is also safe to store the drug at room temperature between 1 to 30 degrees Celsius, avoiding extremes of heat or cold.

Appearance and packaging

Appearance

Bright pink, biconvex, round tablet

Package unit

30 tablets/bottle, 100 tablets/bottle

Same-ingredient medicines

Even with the same ingredient, strength, dosage form and how it is taken can differ.

Even with the same ingredient, the dose and directions can differ by strength and dosage form. Talk to a doctor or pharmacist before switching from a medication you are already taking.

Questions about this medicine

No questions yet.

For anything that needs medical judgment, consult a doctor or pharmacist.

Related searches

Search tags

Suggested searches

This drug information is based on data provided by the Korea Ministry of Food and Drug Safety.
Consult a doctor or pharmacist for accurate dosage, administration, and usage instructions.